LD-2 disclosure · 2nd Quarter - Report
ERISA INDUSTRY COMMITTEE
Client
- Location
- District of Columbia · United States of America
Registrant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesTaxation/Internal Revenue Code
Tax treatment of employer-sponsored health benefits; Modernizing high-deductible health plans (HDHPs)/health savings accounts(HSAs); Treatment of excepted benefits for stand-alone telehealth plans; Telehealth first dollar coverage permenence; Retirement-related tax issues;
LobbyistsJAMES PATRICK GELFAND · ANDREW BANDUCCI · CHRISTINA STROGIS · MELISSA BARTLETT
Covered position (ANDREW BANDUCCI): Professional Staff Member and Workforce Policy Counsel, House Comm. on Education and the Workforce;Labor and Pensions Policy Director, Sen. HELP Comm.;Chief Policy Officer, Pension Benefit Guaranty Corp;Pensions Detailee, Sen. Finance Comm.
Covered position (MELISSA BARTLETT): Privacy Program Specialist, U.S. Department of Health and Human Services, Office of the Secretary, Office for Civil Rights Counsel, U.S. House of Representatives, Committee on Energy and Commerce
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Affordable Care Act, all provisions and related regulations, as applicable to ERISA self-funded health plans; PCORI & comparative effectiveness, coverage mandates on ERISA plans, access to preventive care items and services; ADA and GINA, HIPAA compliance, privacy and security of health information, access to claims data, and all payers claims databases, cybersecurity, artificial intelligence; Coverage of and access to mental health and substance use disorder treatment; Tax treatment of employer-sponsored benefits and insurance; Drug related provisions including: patent reforms, costs, rebates, access to and regulation of generics, and biosimilars, and supply chain concerns; Medical management, value-driven care in public and private coverage; Patient safety and quality; Voluntary coverage of fertility treatment and other women's health issues; Medicare Advantage, Medicare secondary payer, end stage renal disease (ESRD), and retiree health, COBRA, Medicare expansion and public option Health savings accounts and high-deductible health plan modernization; ERISA preemption protection; Clarification of ERISA fiduciary duty standards application to entities; Plan administration; Transparency and accountability in the health care system, vertical integration impacts on health care; Electronic delivery of plan communications; Caregiving support and incentives; Surprise medical billing/No Surprises Act implementation; Hospital billing, consolidation, anti-competitive practices; Telehealth expansion, interstate provider licensing; CAA implementation; Access to preventive treatments and screenings related to chronic kidney care and other conditions such as colorectal cancer;